Skip to main content

Alternative Specimen Collection Options

Alternative Specimen Collection Options

Click here to listen


Today’s podcast discussion will focus on the importance of drug monitoring and the benefits of “alternative” sample collection options during the COVID-19 pandemic. Key information shared will include:

  • How clinical drug monitoring is a critical tool to help assess prescription compliance with controlled substances and help identify drug misuse
  • Situations, including the COVID-19 pandemic, when in-office collection isn't always possible
  • Quest Diagnostics’ offerings for alternative specimen collection options, including:
    - Self /At-Home collection
    - Patient Service Center collection
  • How alternative collection options can help ensure your patients get the testing they need

The episode will feature Quest Senior Medical Advisor, Dr Jeff Gudin, and Jason Suomala, Senior Product Manager for the Quest Diagnostics Drug Monitoring and Toxicology division.

Date: Wednesday, April 21, 2021

Presenter(s): Gudin, J, Suomala, J